首页> 外文期刊>Pharmacology and Toxicology: An International Journal >Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.
【24h】

Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.

机译:赖诺普利和依那普利单独或与普萘洛尔联用对健康志愿者的血浆血管紧张素转化酶活性和循环肾素的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The effects on plasma angiotensin-converting enzyme activity and renin activity of the two long-acting angiotensin-converting enzyme inhibitors, lisinopril and enalapril, alone and in combination with propranolol were studied. In an open, randomised, cross-over design 12 healthy volunteers received orally enalapril 20 mg alone, enalapril 20 mg in combination with propranolol 80 mg, lisinopril 20 mg alone, and lisinopril 20 mg in combination with propranolol 80 mg. Plasma angiotensin-converting enzyme activity and plasma renin activity were measured for 24 h after each treatment period. Lisinopril and enalapril reduced plasma angiotensin converting enzyme activity substantially and equally at six hr (-70%, P<0.05) and 12 hr (-65%, P<0.05), irrespective of combination with propranolol. At 24 hr plasma angiotensin-converting enzyme activity remained significantly suppressed only after lisinopril (-60%, P<0.05). Plasma renin activity increased almost ten times after ingestion of both angiotensin-converting enzyme inhibitors, but the effect lasted significantly longer after lisinopril than after enalapril. Beta-Adrenergic blockade blunted the effect on the increase in plasma renin activity induced by both angiotensin-converting enzyme inhibitors. Our results show that the effect of lisinopril on plasma angiotensin-converting enzyme activity and plasma renin activity lasted longer than that of enalapril. beta-Adrenergic blockade suppressed the effect on elevated plasma renin activity, but did not influence the effect of angiotensin-converting enzyme inhibitors on plasma angiotensin-converting enzyme activity.
机译:研究了两种长效血管紧张素转化酶抑制剂赖诺普利和依那普利单独使用或与普萘洛尔联用对血浆血管紧张素转化酶活性和肾素活性的影响。在开放,随机,交叉设计中,12名健康志愿者分别接受口服依那普利20 mg,依那普利20 mg联合普萘洛尔80 mg,赖诺普利20 mg单独和赖诺普利20 mg与普萘洛尔80 mg组合口服。在每个治疗期后24小时测量血浆血管紧张素转化酶活性和血浆肾素活性。利诺普利和依那普利在6小时(-70%,P <0.05)和12小时(-65%,P <0.05)时均显着相等地降低血浆血管紧张素转化酶活性,而与普萘洛尔组合使用均如此。仅在赖诺普利用药后(24%),血浆血管紧张素转化酶活性仍显着抑制(-60%,P <0.05)。摄入两种血管紧张素转换酶抑制剂后,血浆肾素活性几乎增加了十倍,但赖诺普利后的作用持续时间比依那普利后显着更长。 β-肾上腺素能阻滞减弱了两种血管紧张素转化酶抑制剂诱导的血浆肾素活性增加的作用。我们的结果表明,赖诺普利对血浆血管紧张素转化酶活性和血浆肾素活性的作用持续时间长于依那普利。 β-肾上腺素能阻滞抑制了血浆肾素活性升高的作用,但没有影响血管紧张素转化酶抑制剂对血浆血管紧张素转化酶活性的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号